In silico drug discovery of Acetylcholinesterase and Butyrylcholinesterase enzymes inhibitors based on Quantitative Structure-Activity Relationship (QSAR) and drug-likeness evaluation
Author:
Publisher
Elsevier BV
Subject
Inorganic Chemistry,Organic Chemistry,Spectroscopy,Analytical Chemistry
Reference83 articles.
1. Treatment of Alzheimer's disease: Current status and new perspectives;Scarpini;Lancet Neurol,2003
2. B. Vellas, L. Froelich, C. Sampaio, Commentary on “Health economics and the value of therapy in Alzheimer's disease.” Value therapy for Alzheimer's disease-A European perspective, Alzheimer's Dement. 3 (2007) 152–156. 10.1016/j.jalz.2007.04.382.
3. Alzheimer's disease drug development pipeline: 2018, Alzheimer's Dement;Cummings;Transl. Res. Clin. Interv.,2018
4. Discovery of novel PDE9A inhibitors with antioxidant activities for treatment of Alzheimer's disease;Zhang;J. Enzyme Inhib. Med. Chem.,2018
5. Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease - Demonstration with a panel of antibodies against Tau proteins;Delacourte;Acta Neuropathol,1990
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. In silico studies of alkaloids and their derivatives against N-acetyltransferase EIS protein from Mycobacterium tuberculosis;Journal of Biomolecular Structure and Dynamics;2023-09-20
2. In silico identification of novel heterocyclic compounds combats Alzheimer’s disease through inhibition of butyrylcholinesterase enzymatic activity;Journal of Biomolecular Structure and Dynamics;2023-09-18
3. An Updated Review on Developing Small Molecule Kinase Inhibitors Using Computer-Aided Drug Design Approaches;International Journal of Molecular Sciences;2023-09-11
4. In silico exploration of promising heterocyclic molecules against both acetylcholinesterase and butyrylcholinesterase enzymes;Journal of Biomolecular Structure and Dynamics;2023-07-21
5. Thiazolidinedione–triazole conjugates: design, synthesis and probing of the α-amylase inhibitory potential;Future Medicinal Chemistry;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3